301 – 310 of 343
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Erythropoietin Receptor Expression and Correlation to Tamoxifen Response and Prognosis in Breast Cancer.
(
- Contribution to journal › Article
-
Mark
Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer.
(
- Contribution to journal › Article
-
Mark
High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer.
(
- Contribution to journal › Article
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT
(
- Contribution to journal › Published meeting abstract
-
Mark
Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
(
- Contribution to journal › Article
-
Mark
Long-Term Survival of Breast Ductal Carcinoma In Situ in Women with Different Gene-Expression Types.
(
- Contribution to journal › Published meeting abstract
-
Mark
Differential expression of cytoplasmic and stromal beta-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
(
- Contribution to journal › Published meeting abstract
-
Mark
JAM-A expression positively correlates with poor prognosis in breast cancer patients
(
- Contribution to journal › Article
- 2008
-
Mark
Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer.
(
- Contribution to journal › Article